AposTherapy for Singaporean Patients With Knee Osteoarthritis (OA)
Primary Purpose
Knee Osteoarthritis
Status
Completed
Phase
Not Applicable
Locations
Singapore
Study Type
Interventional
Intervention
AposTherapy (All Phases of Step-cycle {APOS} system, APOS-Medical and Sports Technologies Ltd. Herzliya, Israel)
Sponsored by
About this trial
This is an interventional treatment trial for Knee Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Patients suffering from symptomatic bilateral knee osteoarthritis at the medial compartment for at least six months, fulfilling the ACR clinical criteria for OA of the knee, and having radiographically assessed OA of the knee according to the Kellgren and Lawrence scale.
- Patients with an overall WOMAC score of >2cm (as measured at baseline).
- Males and females between the ages of 50-70.
Exclusion Criteria:
- Patients suffering from acute septic arthritis.
- Patients suffering from inflammatory arthritis.
- Patients who received a corticosteroid injection within 3 months of the study.
- Patients suffering from avascular necrosis of the knee.
- Patients with a history of knee buckling or recent knee injury.
- Patients who have had a joint replacement.
- Patients suffering from neuropathic arthropathy.
- Patients with an increased tendency to fall.
- Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedure.
- Patients with a history of pathological osteoporotic fracture.
- Patients suffering from symptomatic degenerative arthritis in lower limb joints other than the knees.
- Patients with referred pain in the knees from back or hip joint symptoms.
Sites / Locations
- AposTherapy center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Research
Arm Description
Outcomes
Primary Outcome Measures
Changes in self-evaluation questionnaires between baseline and after 6 months of therapy
Western Ontario and MacMaster osteoarthritis questionnaire (WOMAC) and SF-36 Health Survey will be evaluated.
The WOMAC questionnaire is measured on a 10cm visual analogue scale (VAS) and the SF-36 is scored between 0-100.
Secondary Outcome Measures
Changes in spatio-temporal gait parameters between basline and after 6 months of therapy
Full Information
NCT ID
NCT01562652
First Posted
March 14, 2012
Last Updated
March 23, 2012
Sponsor
Apos Medical and Sports Technology Ltd.
1. Study Identification
Unique Protocol Identification Number
NCT01562652
Brief Title
AposTherapy for Singaporean Patients With Knee Osteoarthritis (OA)
Study Type
Interventional
2. Study Status
Record Verification Date
March 2012
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Apos Medical and Sports Technology Ltd.
4. Oversight
5. Study Description
Brief Summary
Osteoarthritis (OA) is the most prevalent form of arthritis in the elderly. It is estimated that 7% of men and 11% of women over the age of 65 have KOA. The most significant symptoms of the disease are pain and functional disability.
This study has two aims:
To characterise the gait patterns and clinical parameters of patients with knee osteoarthritis (KOA) in Singapore at baseline, prior to treatment.
To investigate the changes in gait patterns and the clinical benefits of treatment with a new biomechanical device, AposTherapy, for patients with KOA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Research
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
AposTherapy (All Phases of Step-cycle {APOS} system, APOS-Medical and Sports Technologies Ltd. Herzliya, Israel)
Primary Outcome Measure Information:
Title
Changes in self-evaluation questionnaires between baseline and after 6 months of therapy
Description
Western Ontario and MacMaster osteoarthritis questionnaire (WOMAC) and SF-36 Health Survey will be evaluated.
The WOMAC questionnaire is measured on a 10cm visual analogue scale (VAS) and the SF-36 is scored between 0-100.
Time Frame
Baseline, 6 months
Secondary Outcome Measure Information:
Title
Changes in spatio-temporal gait parameters between basline and after 6 months of therapy
Time Frame
Baseline, 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients suffering from symptomatic bilateral knee osteoarthritis at the medial compartment for at least six months, fulfilling the ACR clinical criteria for OA of the knee, and having radiographically assessed OA of the knee according to the Kellgren and Lawrence scale.
Patients with an overall WOMAC score of >2cm (as measured at baseline).
Males and females between the ages of 50-70.
Exclusion Criteria:
Patients suffering from acute septic arthritis.
Patients suffering from inflammatory arthritis.
Patients who received a corticosteroid injection within 3 months of the study.
Patients suffering from avascular necrosis of the knee.
Patients with a history of knee buckling or recent knee injury.
Patients who have had a joint replacement.
Patients suffering from neuropathic arthropathy.
Patients with an increased tendency to fall.
Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedure.
Patients with a history of pathological osteoporotic fracture.
Patients suffering from symptomatic degenerative arthritis in lower limb joints other than the knees.
Patients with referred pain in the knees from back or hip joint symptoms.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yoav Aloni
Organizational Affiliation
AposTherapy Singapore Pte Ltd. #05-07, 1 Orchard Boulevard Singapore 248649
Official's Role
Principal Investigator
Facility Information:
Facility Name
AposTherapy center
City
Singapore
ZIP/Postal Code
248649
Country
Singapore
12. IPD Sharing Statement
Citations:
PubMed Identifier
24383821
Citation
Elbaz A, Mor A, Segal G, Aloni Y, Teo YH, Teo YS, Das-De S, Yeo SJ. Patients with knee osteoarthritis demonstrate improved gait pattern and reduced pain following a non-invasive biomechanical therapy: a prospective multi-centre study on Singaporean population. J Orthop Surg Res. 2014 Jan 2;9:1. doi: 10.1186/1749-799X-9-1.
Results Reference
derived
Learn more about this trial
AposTherapy for Singaporean Patients With Knee Osteoarthritis (OA)
We'll reach out to this number within 24 hrs